Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 45351.23 Crore) operating in Pharmaceuticals sector.
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 3781.79 Crore, up 7.20 % from last quarter Sales of Rs 3527.86 Crore and down -11.99 % from last year same quarter Sales of Rs 4296.90 Crore Company reported net profit after tax of Rs 213.08 Crore in latest quarter.
The brokerage values LPC at 25x 12M forward earnings to arrive at Target Price of INR1,130. Maintain Buy.
Promoters held 46.9 per cent stake in the company as of June 30, 2020, while FIIs held 20.4 per cent, DIIs 20.1 per cent and public and others 12.6 per cent.